Repigmentation by body region in patients with vitiligo treated with ruxolitinib cream over 52 weeks

Affiliations

• ¹ Centre Hospitalier Universitaire de Nice, Université Côte d'Azur, Nice, France.
• ² INSERM U1065, C3M, Université Côte d'Azur, Nice, France.
• ³ University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
• ⁴ Palo Alto Foundation Medical Group, Mountain View, California, USA.
• ⁵ University of Texas Southwestern Medical Center, Dallas, Texas, USA.
• ⁶ Department of Dermatology and Pediatric Dermatology, National Reference Center for Rare Skin Disorders, Hôpital Saint-André, CNRS, UMR-5164, ImmunoConcEpT, Bordeaux, France.
• ⁷ The Vitiligo & Pigmentation Institute of Southern California, Los Angeles, California, USA.
• ⁸ Incyte Corporation, Wilmington, Delaware, USA.
• ⁹ Henri Mondor University Hospital and Université Paris-Est Créteil Val de Marne, Paris, France.
• ¹⁰ Indiana University School of Medicine, Indianapolis, Indiana, USA.